Improving access to clinical trials
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to be part of one.
Expanding trial access – ICR report
Our 2021 report, Clinical trials in cancer, reveals the impact of the Covid-19 pandemic on cancer trials and highlights longstanding barriers to expanding clinical trial access to more people with cancer. But Covid-19 also offers clues to a recovery that can get new treatments to cancer patients more quickly.

News: Cancer trial recruitment drops by 60 per cent during pandemic
The number of cancer patients entering clinical trials has plummeted during the pandemic – denying many thousands the latest treatment options and delaying drug development. Here, cancer experts set out their findings about the barriers to carrying out clinical trials in the UK and proposals for boosting participation.Latest ICR News

From data to discovery: the impact of statistics in cancer research
Every five years, World Statistics Day is celebrated globally to recognise the vital role statistics plays in shaping societies, our research and supporting evidence-based decision-making. The fourth observance, on 20 October 2025, is held under the theme ‘Quality statistics and data for everyone’.
.png?sfvrsn=364266fe_1)
‘Smart jab’ shows promise in treating advanced head and neck cancer
A new type of cancer treatment which is given via an injection under the skin has shown early signs of success in patients with advanced head and neck cancer.

New drug shows dramatic effect in shrinking lung cancer tumours
A new drug is having a dramatic effect on shrinking lung cancer tumours, according to new research.

MRI scan before bladder cancer surgery shown to save lives
Giving patients with suspected bladder cancer an MRI scan before surgery could mean they would be treated more quickly, leading to fewer deaths due to the disease, new ICR-led research suggests.